SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis

Pediatrics International

Volumn 54, Issue 4, 2012, Pages 447-454

  Yang, Xi ^a   Miyawaki, Toshio ^a   Kanegane, Hirokazu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Epstein Barr virus; hemophagocytic lymphohistiocytosis; signaling lymphocytic activation molecule associated protein; X linked inhibitor of apoptosis; X linked lymphoproliferative syndrome

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CYTOKINE RELEASE; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEVER; FLOW CYTOMETRY; GENE MUTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HUMAN; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PEDIATRICIAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

CHILD; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84864408103     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03683.x     Document Type: Review

References (66)

1. Farquhar JW, Claireaux AE,. Familial haemophagocytic reticulosis. Arch. Dis. Child. 1952; 27: 519-25.
2. Allen CE, Yu X, Kozinetz CA, Mcclain KL,. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2008; 50: 1227-35. (Pubitemid 351555548)
3. Henter JI, Horne A, Aricõ M, et al,. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007; 48: 124-31. (Pubitemid 44958267)
4. Zhang K, Jordan MB, Marsh RA, et al,. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 2011; 118: 5794-8.
5. zur Stadt U, Beutel K, Kolberg S, et al,. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX, and RAB27A. Hum. Mutat. 2006; 27: 62-8. (Pubitemid 43042967)
6. Verbsky JW, Grossman WJ,. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann. Med. 2006; 38: 20-31. (Pubitemid 43177784)
7. Sumegi J, Huang D, Lanyi A, et al,. Correlation of mutations of the SH2D1A gene and Epstein Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000; 96: 3118-25.
8. Nichols KE, Harkin DP, Levitz S, et al,. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 13765-70. (Pubitemid 28523047)
9. Coffey AJ, Brooksbank RA, Brandau O, et al,. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998; 20: 129-35. (Pubitemid 28455444)
10. Sayos J, Wu C, Morra M, et al,. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395: 462-9. (Pubitemid 28462434)
11. Rigaud S, Fondanèche MC, Lambert N, et al,. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-4. (Pubitemid 44684766)
12. Listen P, Roy N, Tamai K, et al,. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-53. (Pubitemid 26033078)
13. Duckett CS, Nava VE, Gedrich RW, et al,. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 1996; 15: 2685-94. (Pubitemid 26176246)
14. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL,. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 4974-8.
15. Zhao M, Kanegane H, Kobayashi C, et al,. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry. Cytometry B Clin. Cytom. 2011; 80: 8-13.
16. Yang X, Kanegane H, Nishida N, et al,. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 2012; 32: 411-20.
17. Marsh RA, Bleesing JJ, Filipovich AH,. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J. Immunol. Methods 2010; 362: 1-9.
18. Gulez N, Aksu G, Berdeli A, et al,. X-linked lymphoproliferative syndrome and common variable immunodeficiency may not be differentiated by SH2D1A and XIAP/BIRC4 genes sequence analysis. Case Report Med. 2011; 121258: 1- 5.
19. Bryceson YT, Pende D, Maul-Pavicic A, et al,. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 2012; 119: 2754-63.
20. Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB,. Perforin is a critical physiologic regulator of T-cell activation. Blood 2011; 118: 618-26.
21. Ishii E, Ueda I, Shirakawa R, et al,. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood 2005; 105: 3442-8. (Pubitemid 40628184)
22. Ma CS, Nichols KE, Tangye SG,. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 2007; 25: 337-79. (Pubitemid 46705271)
23. Ma CS, Pittaluga S, Avery DT, et al,. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J. Clin. Invest. 2006; 116: 322-33. (Pubitemid 43228349)
24. Cuss AK, Avery DT, Cannons JL, et al,. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 2006; 176: 1506-16. (Pubitemid 43134294)
25. Tangye SG, Hodgkin PD,. Divide and conquer: the importance of cell division in regulating B-cell responses. Immunology 2004; 112: 509-20. (Pubitemid 39061475)
26. Chan B, Lanyi A, Song HK, et al,. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 2003; 5: 155-60. (Pubitemid 36204198)
27. Latour S, Roncagalli R, Chen R, et al,. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell Biol. 2003; 5: 149-54. (Pubitemid 36204197)
28. Latour S, Gish G, Helgason CD, et al,. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2001; 2: 681-90. (Pubitemid 32747156)
29. Cannons JL, Yu LJ, Hill B, et al,. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 2004; 21: 693-706. (Pubitemid 39489893)
30. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C,. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005; 105: 4722-9. (Pubitemid 40807295)
31. + T cells against EBV-infected cells. Blood 2005; 105: 4383-9. (Pubitemid 40720785)
32. Bottino C, Falco M, Parolini S, et al,. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 2001; 194: 235-46. (Pubitemid 32730798)
33. Flaig RM, Stark S, Watzl C,. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 2004; 172: 6524-7. (Pubitemid 38669084)
34. Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Lator S, Veillette A,. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat. Immunol. 2009; 10: 973-80.
35. Fischer A, Latour S, de Saint Basile G,. Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 2007; 19: 348-53. (Pubitemid 46705487)
36. Latour S,. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr. Opin. Allergy Clin. Immunol. 2007; 7: 510-4. (Pubitemid 350076446)
37. Filipovich AH, Zhang K, Snow AL, Marsh RA,. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 2010; 116: 3398-408.
38. Hinds MG, Norton RS, Vaux DL, Day CL,. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat. Struct. Biol. 1999; 6: 648-51. (Pubitemid 29318954)
39. Holcik M, Gibson H, Korneluk RG,. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001; 6: 253-61. (Pubitemid 32708519)
40. Salvesen GS, Duckett CS,. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 2002; 3: 401-10. (Pubitemid 34685698)
41. Vaux DL, Silke J,. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 2005; 6: 287-97. (Pubitemid 40516895)
42. Galbán S, Duckett CS,. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010; 17: 54-60.
43. de Saint Basile G, Ménasché G, Latour S,. Inherited defects causing hemophagocytic lymphohistiocytic syndrome. Ann. N. Y. Acad. Sci. 2011; 1246: 64-76.
44. Braun M, Melchers I, Peter HH, Illges H,. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. Int. Immunol. 1998; 10: 1197-202. (Pubitemid 28362694)
45. Filipovich AH,. The expanding spectrum of hemophagocytic lymphohistiocytosis. Curr. Opin. Allergy Clin. Immunol. 2011; 11: 512-6.
46. Torti L, Larocca LM, Massini G, et al,. Epstein-Barr virus (EBV)-associated hemophagocytic syndrome. Mediterr. J. Hematol. Infect. Dis. 2012; 7: e2012008.
47. Kasahara Y, Yachie A,. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit. Rev. Oncol. Hematol. 2002; 44: 283-94. (Pubitemid 35435293)
48. Yang X, Wada T, Imadome K, et al,. Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2. Herpesviridae 2012; 3: 1.
49. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB,. Characterization of XIAP-deficient Mice. Mol. Cell. Biol. 2001; 21: 3604-8. (Pubitemid 32381796)
50. Huck K, Feyen O, Niehues T, et al,. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J. Clin. Invest. 2009; 119: 1350-8.
51. Ishii E, Ohga S, Imashuku S, et al,. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int. J. Hematol. 2007; 86: 58-65. (Pubitemid 47204491)
52. Seemayer TA, Gross TG, Egeler RM, et al,. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 1995; 38: 471-8.
53. Nichols KE, Hom J, Gong SY, et al,. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 2005; 11: 340-5. (Pubitemid 40460564)
54. Dutz JP, Benoit L, Wang X, et al,. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 2001; 97: 95-100. (Pubitemid 32061247)
55. Kanegane H, Ito Y, Ohshima K, et al,. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis. Am. J. Hematol. 2005; 78: 130-3. (Pubitemid 40194106)
56. Pachlopnik-Schmid J, Canioni D, Moshous D, et al,. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 2011; 117: 1522-9.
57. Marsh RA, Madden L, Kitchen BJ, et al,. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 2010; 116: 1079-82.
58. Kanegane H, Yang X, Zhao M, et al,. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis. Pediatr. Allergy Immunol. 2012; [Epub ahead of print].
59. Booth C, Gilmour KC, Veys P, et al,. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011; 117: 53-62.
60. Veillette A, Dong Z, Pérez-Quintero LA, Zhong MC, Cruz-Munoz ME,. Importance and mechanism of "switch" function of SAP family adapters. Immunol. Rev. 2009; 232: 229-39.
61. Zhao M, Kanegane H, Ouchi K, Imamura T, Latour S, Miyawaki T,. A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica 2010; 95: 688-9.
62. Schimmer AD, Dalili S, Batey RA, Riedl SJ,. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006; 13: 179-88. (Pubitemid 43102202)
63. Krieg A, Correa RG, Garrison JB, et al,. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl. Acad. Sci. U.S.A. 2009; 106: 14524-9.
64. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL,. How I treat hemophagocytic lymphohistiocytosis. Blood 2011; 118: 4041-52.
65. Janka GE, Schneider EM,. Modern management of children with haemophagocytic lymphohistiocytosis. Br. J. Haematol. 2004; 124: 4-14. (Pubitemid 38021618)
66. Milone MC, Tsai DE, Hodinka RL, et al,. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 2005; 105: 994-6. (Pubitemid 40170866)